Perineural Versus Systemic Dexamethasone to Prolong Regional Anesthesia in Front Foot Surgery
ADRIATIC
2 other identifiers
interventional
100
1 country
1
Brief Summary
Both perineural and systemic dexamethasone administration allows an increase in analgesic duration of regional anesthesia. There is a lack of data to determine wich route allows a longer analgesic effect. This study aims to determine wether perineural dexamethasone allows a longer analgesic duration than systemic route in combination with regional anesthesia (Ropivacaine 0.375%) for front foot surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Nov 2016
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 6, 2016
CompletedFirst Posted
Study publicly available on registry
September 19, 2016
CompletedStudy Start
First participant enrolled
November 22, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 23, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 23, 2017
CompletedJune 16, 2017
June 1, 2017
6 months
September 6, 2016
June 15, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
time to the first opioids request
during the first 48 hours
Secondary Outcomes (3)
occurrence of nausea or vomiting
at day 1
overall satisfaction regarding pain relief management
at day 1
any significant side effects
during the first 7 days after surgery.
Study Arms (2)
Perineural group
EXPERIMENTAL1cc (4mg) of dexamethasone will be administrated in perineural injection. 2.5cc of isotonic saline solution will be administrated in systemic injection.
systemic group
EXPERIMENTAL1cc of isotonic saline will be administrated in perineural injection. 2.5cc (10mg) of dexamethasone will be administrated in systemic injection.
Interventions
Eligibility Criteria
You may qualify if:
- front foot surgery with metacarpal osteotomy under regional anesthesia
- \>18 years old
- consent to participate in the study
You may not qualify if:
- refusal to participate
- pregnancy
- feeding
- pre existing neuropathy
- ropivacaine allergy
- paracetamol allergy
- liver failure
- cardiac failure
- ketoprofen allergy
- gastric ulcer within the previous year
- tramadol allergy
- history of epilepsy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Clermont-Ferrand
Clermont-Ferrand, 63003, France
Related Publications (1)
Marty P, Rontes O, Chassery C, Vuillaume C, Basset B, Merouani M, Marquis C, Bataille B, Chaubard M, Mailles MC, Ferre F, Delbos A. Perineural Versus Systemic Dexamethasone in Front-Foot Surgery Under Ankle Block: A Randomized Double-Blind Study. Reg Anesth Pain Med. 2018 Oct;43(7):732-737. doi: 10.1097/AAP.0000000000000769.
PMID: 29630032DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Michel CONSTANTIN
University Hospital, Clermont-Ferrand
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 6, 2016
First Posted
September 19, 2016
Study Start
November 22, 2016
Primary Completion
May 23, 2017
Study Completion
May 23, 2017
Last Updated
June 16, 2017
Record last verified: 2017-06